For patients with early stage resected giant cell lung cancer and other less common histologies, are there any specific considerations for adjuvant therapy?  

Giant cell carcinomas/pleomorphic carcinomas/sarcomatoid carcinomas are difficult, and typically aggressive entities. In reviewing the literature, there is precious little data to guide the selection of cytotoxic chemotherapy (most reports are pathology studies, some case reports, and unfortunately,...